U.S. flag

An official website of the United States government

NC_012920.1(MT-ATP6):m.9185T>C AND Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Jun 14, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000754648.3

Allele description [Variation Report for NC_012920.1(MT-ATP6):m.9185T>C]

NC_012920.1(MT-ATP6):m.9185T>C

Gene:
MT-ATP6:mitochondrially encoded ATP synthase 6 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Genomic location:
Preferred name:
NC_012920.1(MT-ATP6):m.9185T>C
Other names:
MTATP6, 9185T-C, LEU220PRO; L220P
HGVS:
  • NC_012920.1:m.9185T>C
  • NC_012920.1:g.9185T>C
  • m.9185T>C
  • p.Leu220Pro
Protein change:
LEU220PRO
Links:
Genetic Testing Registry (GTR): GTR000500595; OMIM: 516060.0008; dbSNP: rs199476138
NCBI 1000 Genomes Browser:
rs199476138
Observations:
2

Condition(s)

Name:
Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1
Synonyms:
Mitochondrial complex v (atp synthase) deficiency, mitochondrial type 1
Identifiers:
MONDO: MONDO:0027069; MedGen: C3275684; OMIM: 500015

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000030506OMIM
no assertion criteria provided
Pathogenic
(Apr 15, 2007)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV002580116MGZ Medical Genetics Center
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jun 14, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineyes2not providednot providednot providednot providedclinical testing

Citations

PubMed

Late onset Leigh syndrome and ataxia due to a T to C mutation at bp 9,185 of mitochondrial DNA.

Castagna AE, Addis J, McInnes RR, Clarke JT, Ashby P, Blaser S, Robinson BH.

Am J Med Genet A. 2007 Apr 15;143A(8):808-16.

PubMed [citation]
PMID:
17352390

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From OMIM, SCV000030506.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In a patient with mitochondrial complex V (ATP synthase) deficiency mitochondrial type 1 (MC5DM1; 500015), resulting in Leigh syndrome (see 256000), Castagna et al. (2007) identified a heteroplasmic 9185T-C transition in the MTATP6 gene, resulting in a leu220-to-pro (L220P) substitution in the fifth transmembrane helix at the inner surface of the outer mitochondrial membrane. After a normal development, the boy presented at age 8.5 years with a 3-month history of frequent falls, ataxia, slowed speech, poor concentration, bilateral pes cavus, and absent ankle reflexes. Three months later, he developed saccadic paresis and nystagmus and rapidly deteriorated into a comatose state, followed by death. Brain MRI showed symmetric hyperintense signals in the basal ganglia with prominent cerebellar involvement, consistent with Leigh syndrome. The proband had a similarly affected brother, and both boys had greater than 90% mutant DNA levels. The mother and a maternal uncle had isolated peripheral neuropathy and ataxia with 86% and 85% heteroplasmy for the mutation, respectively. Family history revealed 4 additional maternal relatives with the mutation: 2 had Leigh syndrome, and 2 had isolated ataxia. Percentage of heteroplasmy correlated with the severity of the phenotype. Studies of the proband's mitochondria showed a 30% decrease in ATPase activity, although the overall process of ATP synthesis was not affected.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From MGZ Medical Genetics Center, SCV002580116.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided2not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided2not providednot providednot provided

Last Updated: Oct 8, 2024